alcohol and bpc 157 The peptide boom: why everyone's suddenly talking about BPC-157, its bold claims - the hidden risks BioWorld

Homocysteine and cardiovascular disease Observational studies indicate that even moderately elevated blood concentrations of homocysteine raise the risk of cardiovascular disease (CVD), although randomized controlled trials of homocysteine-lowering therapy have generally not translated to reductions in adverse cardiovascular outcomes (26, 27)

used Rogans podcast recently to announce that the FDA would reclassify certain peptides to make it easier for compounders to produce and sell them

There are a few things to consider if levels don't rise despite supplementation

Variant CJD

The peptides anti-inflammatory effects operate through several interconnected pathways